Search

Author/Creator Ziepert, M.

2. ANTI‐INFECTIVE PROPHYLAXIS WITH ACICLOVIR AND COTRIMOXAZOLE SIGNIFICANTLY REDUCES THE RATE OF INFECTIONS AND THERAPY‐ASSOCIATED DEATHS IN ELDERLY PATIENTS WITH DLBCL UNDERGOING R‐CHOP IMMUNOCHEMOTHERAPY. (June 2017)

Authors:
Murawski, N.; Amam, J.; Altmann, B.; Ziepert, M.; Haenel, M.; Viardot, A.; Neubauer, A.; Held, G.; Truemper, L.; Dreyling, M.; Kanz, L.; Hallek, M.; Schmitz, N.; Heintges, T.; Koelbel, C.; Poeschel, V.; Pfreundschuh, M.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
200
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. COMPARISON OF CLINICAL SCORING SYSTEMS IN AGGRESSIVE B‐CELL LYMPHOMAS (BCL): AN INDIVIDUAL PATIENT‐LEVEL ANALYSIS ACROSS INTERNATIONAL TRIAL. (12th June 2019)

Authors:
Schmitz, N.F.; Dixon, J.G.; Salles, G.; Wall, A.; Cunningham, D.; Poeschel, V.; Haioun, C.; Tilly, H.; Ghesquieres, H.; Ziepert, M.; Flament, J.; Flowers, C.; Shi, Q.; Ruppert, A.S.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
248
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. FIRST‐LINE THERAPY OF ELDERLY PATIENTS WITH DLBCL‐A COMPARISON OF STUDY PATIENTS TREATED WITH R‐CHOP ON THE RICOVER‐60 TRIAL AND PATIENTS TREATED WITH R‐CYCLOPHOSPHAMIDE, EPIRUBICIN, VINDESINE, PREDNISONE (R‐EpiVDSP) AT PEKING UNIVERSITY. (12th June 2019)

Authors:
Yang, S.; Ziepert, M.; Altmann, B.; Pöschel, V.; Held, G.; Lu, J.; Schmitz, N.; Huang, X.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
426
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. FIRST‐LINE THERAPY OF T‐CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION ‐ FINAL RESULTS OF THE AATT STUDY. (12th June 2019)

Authors:
Tournilhac, O.; Truemper, L.; Ziepert, M.; Bouabdallah, K.; Nickelsen, M.; Maury, S.; Reimer, P.; Jaccard, A.; Herr, W.; Wilhelm, M.; Cartron, G.; Wulf, G.; Sanhes, L.; Dreger, P.; Lamy, T.; Kroschinsky, F.; Lindemann, H.; Roussel, M.; Viardot, A.; Sibon, D.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
99
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. INTENSIVE IMMUNOCHEMOTHERAPY (R‐CHOEP) VS HIGH‐DOSE IMMUNOCHEMOTHERAPY (R‐MegaCHOEP) IN YOUNG PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA: A 10‐YEAR LONG‐TERM FOLLOW‐UP. (12th June 2019)

Authors:
Frontzek, F.; Ziepert, M.; Nickelsen, M.; Altmann, B.; Glaß, B.; Hänel, M.; Trümper, L.; Held, G.; Bentz, M.; Borchmann, P.; Dreyling, M.; Viardot, A.; Metzner, B.; Kroschinsky, F.; Staiger, A.M.; Ott, G.; Rosenwald, A.; Löffler, M.; Lenz, G.; Schmitz, N.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
431
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Obesity negatively impacts outcome in elderly female patients with aggressive B‐cell lymphomas treated with R‐CHOP2: results from prospective trials of the German high grade non‐Hodgkin's lymphoma trial group. (28th November 2017)

Authors:
Hohloch, K.; Altmann, B.; Pfreundschuh, M.; Loeffler, M.; Schmitz, N.; Zettl, F.; Ziepert, M.; Trümper, L.
Journal:
British journal of haematology
Issue:
Volume 180:Number 2(2018)
Page Start:
236
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. PROGNOSTIC FACTORS AND IMPACT OF ETOPOSIDE IN ADULTS WITH SYSTEMIC ALK‐POSITIVE ANAPLASTIC LARGE‐CELL LYMPHOMA: A POOLED ANALYSIS OF SIX STUDIES. (June 2017)

Authors:
Sibon, D.; Nguyen, D.; Schmitz, N.; Suzuki, R.; Feldman, A.L.; Gressin, R.; Lamant, L.; Weisenburger, D.; Nakamura, S.; Ziepert, M.; Maurer, M.J.; Bast, M.; Armitage, J.O.; Vose, J.M.; Tilly, H.; Jais, J.P.; Savage, K.J.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
240
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. RADIOTHERAPY TO BULKY DISEASE PET‐NEGATIVE AFTER IMMUNOCHEMOTHERAPY CAN BE SPARED IN ELDERLY DLBCL PATIENTS: RESULTS OF a PLANNED INTERIM ANALYSIS OF THE FIRST 187 PATIENTS WITH BULKY DISEASE TREATED IN THE OPTIMAL > 60 STUDY OF THE DSHNHL. (June 2017)

Authors:
Pfreundschuh, M.; Christofyllakis, K.; Altmann, B.; Ziepert, M.; Haenel, M.; Viardot, A.; Neubauer, A.; Held, G.; Truemper, L.; Dreyling, M.; Kanz, L.; Hallek, M.; Schmitz, N.; Heintges, T.; Kölbel, C.; Buecker, A.; Ruebe, C.; Hellwig, D.; Berdel, C.; Poeschel, V.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
129
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗